Press Release: AvantGen : AvantGen Receives Milestone Payment for First Patient Dosed in Phase 1 Study with Kite's Investigational CAR-T Therapy

SAN DIEGO, CA, UNITED STATES, March 4, 2024 /⁨EINPresswire.com⁩/ -- AvantGen Inc., a leader in antibody discovery and engineering, announced today that it has received the first milestone payment from Kite, a Gilead Company, for the achievement of the ...